mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion. - Gentile C; Feng WW; Lenahan SM; Ying AW; Card DC; Wu FTH; Pham NA; Radulovich N; Cao PM; Hueniken K; Li Q; Tsao MS; et al. (BioRxiv : the preprint server for biology, 2026)